Business
Embla Medical hf: Share Buyback Program Completed
Embla Medical hf: Share Buyback Program
About this update from Embla Medical Hf
Announcement no. 36/2026 17 July 2026 Reykjavik, Iceland / Copenhagen, Denmark , 17 July 2026 . Embla Medical (Nasdaq Copenhagen: EMBLA), a leading global provider of innovative mobility solutions, today announced the completion of the share buyback program, which was announced in Company Announcement no. 3/2025 dated 7 February 2025 . Following are the last transactions carried out under the current share buyback program. Transaction date No. of shares Avg. purchase price in DKK Transaction value in DKK 13 July 2026 10,000 26.47 264,747 14 July 2026 10,000 26.38 263,793 15 July 2026 10,000 26.60 266,041 16 July 2026 10,000 26.42 264,152 Total 40,000 26.47 1,058,733 The purpose of the Program was to reduce the Company's share capital and adjust the capital structure by distributing capital to shareholders in line with the Company's Capital Structure and Capital Allocation Policy. Embla Medical could acquire 2,000,000 shares under the Program for total consideration not exceeding USD 10 million up until and including December 31, 2026 . Embla Medical acquired 2,007,862 shares under the Program at an average price of DKK 27.86 . Following the last transactions, Embla Medical currently holds 2,235,201 shares, corresponding to 0.53% of the Company's total share capital. The Program on Nasdaq Copenhagen was carried out in accordance with Regulation No. 596/2014 of the European Parliament and of the Council on market abuse ("MAR"), and the Commission's delegated regulation 2016/1052. Further information Klaus Sindahl , Head of Investor Relations, [email protected], +45 5363 0134 Embla Medical press releases by e-mail If you wish to receive Embla Medical press releases by e-mail, please register at http://www.emblamedical.com/investors About Embla Medical Embla Medical (Nasdaq Copenhagen: EMBLA) was founded in Reykjavik in 1971 with the mission to improve people's mobility. Embla Medical is home to several brands renowned for positively impacting people's health and well-being. They include Össur, a leading global provider of prosthetics and bracing and supports solutions; FIOR & GENTZ, an innovative developer of neuro orthotics; and College Park Industries, creators of custom-built prosthetic solutions. Embla Medical also provides patients with world-class care through a global network of Orthotic and Prosthetic (O&P) facilities. Embla Medical is committed to sustainable business practices and is signatory to the UN Global Compact, UN Women's Empowerment Principles, and contributes to the UN Sustainable Development Goals. The company's climate targets have been verified by the Science Based Targets initiative. Embla Medical operates globally and has more than 4,000 employees. www.emblamedical.com Embla Medical was formerly listed as Össur (OSSR) on Nasdaq Copenhagen until 8 April 2024. https://news.cision.com/embla-medical-hf-/r/embla-medical-hf--share-buyback-program-completed,c4375816 https://mb.cision.com/Main/18404/4375816/4197910.pdf (c) 2026 Cision. All rights reserved., source Press Releases - English